NEW YORK, Aug. 1 (GenomeWeb News) - Cellumen and RheoGene announced last week that they have entered into a non-exclusive commercial licensing agreement under which Cellumen will use RheoGene's RheoSwitch inducible gene regulation technology to develop cell biology screening products.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.